Copyright
©The Author(s) 2020.
World J Gastroenterol. Mar 28, 2020; 26(12): 1231-1241
Published online Mar 28, 2020. doi: 10.3748/wjg.v26.i12.1231
Published online Mar 28, 2020. doi: 10.3748/wjg.v26.i12.1231
Table 1 Age and venous thromboembolism risk
Ref. | Findings | Statistics | |
Kappelman et al[19] | IBD patients ≤ 20 are at increased risk of VTE compared to age and sex- matched non-IBD patients | Hazard ratio 6.0 (95%CI: 2.5-14.7) for DVT Hazard ratio 6.4 (95%CI: 2.0-20.3) for PE | |
Annual incidence of VTE is higher in older patients than in younger patients with IBD | Age | Incidence | |
≤ 20 yr | 8.9/10000 persons-years | ||
> 60 yr | 54.6/10000 persons-years | ||
Nylund et al[20] | Hospitalized IBD children/adolescents are at increased risk of developing VTE compared to non-IBD hospitalized children/ adolescents | Relative risk 2.36 (95%CI: 2.15-2.58) | |
Odds of VTE increased as age increased | Odds ratio 2.32 (95%CI: 2.26-2.38) | ||
Ando et al[22] | IBD patients > 50 have an increased odds of developing VTE | Odds ratio 3.52 (95%CI: 1.25-9.94) | |
Nguyen et al[5] | Each incremental decade in age was associated with increased odds of developing VTE | Odds ratio 1.20 (95%CI: 1.15-1.25) | |
Faye et al[23] | Age > 30 had an increased risk of VTE readmission compared with patients younger than 18 years of age | Age (yr) | Relative risk |
31-40 | 2.10 (95%CI: 1.29-3.42) | ||
41-50 | 2.08 (95%CI: 1.28-3.37) | ||
51-65 | 3.74 (95%CI: 2.35-5.94) | ||
66-80 | 4.04 (95%CI: 2.54-6.44) | ||
> 80 | 3.06 (95%CI: 1.87-5.02) | ||
McCurdy et al[24] | IBD patients > 45 have an increased odds of developing VTE post-discharge | 3.76 odds ratio (95%CI: 1.80-7.89) |
Table 2 Pregnancy and venous thromboembolism risk
Ref. | Findings | Statistics | ||
Hansen et al[29] | Pregnant IBD patients are at increased risk of developing VTE as compared to pregnant non-IBD patients | Relative risk 1.67 (95%CI: 1.15-2.41) | ||
Postpartum IBD patients are at a higher risk of developing VTE than postpartum non-IBD patients | Relative risk 2.10 (95%CI: 1.33-3.30) | |||
Incidence of VTE is greatest in postpartum IBD women | Group | Incidence rate | ||
Pregnant non-IBD | 2.41 (95%CI: 2.33-2.50) | |||
Pregnant IBD | 4.20 (95%CI: 2.83-5.58) | |||
Postpartum non-IBD | 2.88 (95%CI: 2.72-3.04) | |||
Postpartum IBD | 7.03 (95%CI: 3.87-10.20) | |||
Kim et al[30] | Pregnant IBD patients are at increased risk of developing VTE as compared to non-IBD pregnant patients | Relative risk 2.13 (95%CI: 1.66-2.73) | ||
Postpartum IBD patients are at increased risk of developing VTE as compared to postpartum non-IBD patients | Relative risk 2.61 (95%CI: 1.84-3.69) | |||
UC patients are at an increased risk of developing VTE as compared to CD patients both during pregnancy and in postpartum period | Group | Relative risk | ||
Pregnant UC vs CD patients | 2.24 (95%CI: 1.60-3.11) | |||
Postpartum UC vs CD patients | 2.85 (95%CI: 1.79-4.52) |
Table 3 Disease activity and venous thromboembolism risk
Ref. | Findings | Statistics |
Grainge et al[3] | IBD flares are associated with increased risk of developing VTE as compared to non-IBD matched controls | Hazard ratio 8.40 (95%CI: 5.50-12.80) |
Hansen et al[29] | IBD flare during pregnancy is associated with increased risk of developing VTE as compared to non-IBD pregnant patients (also compared to IBD pregnant patients without a flare) | Unadjusted relative risk 2.64 (95%CI: 1.69-4.14) |
Bollen et al[32] | A significant proportion of patients had active disease at the time of VTE diagnosis | 60/84 (71%) patients with VTE had active disease |
Table 4 Hospitalization and venous thromboembolism risk
Ref. | Findings | Statistics | |
Grainge et al[3] | Hospitalized IBD patients (regardless of disease activity) have an increased risk of VTE | Hazard ratio 2.10 (95%CI: 1.40-3.20) | |
Absolute risk of VTE in IBD patients is higher during hospitalized periods than during ambulatory periods | Group | Absolute risk | |
Hospitalized | 25.2/1000 person-years | ||
Ambulatory | 1.8/1000 person-years | ||
Nguyen et al[5] | Hospitalized IBD patients with VTE had greater mortality compared to those without VTE | Odds ratio 2.50 (95%CI: 1.83-3.43) | |
Incidence of VTE in hospitalized IBD patients is increasing | Group | Percent rise in odds | |
Hospitalized IBD | 17% rise over 7 yr | ||
Hospitalized non-IBD | 14% rise over 7 yr | ||
Kim et al[35] | Hospitalized IBD patients without a disease flare had higher risk of VTE as compared to age- and sex-matched non-IBD patients | Hazard ratio 12.97 (95%CI: 8.68-19.39) |
Table 5 Medications and venous thromboembolism risk
Medications | Risk of VTE |
5-ASA | Possible ↓ |
Corticosteroids | ↑↑↑ |
Azathioprine and 6-Mercatopurine | Possible ↓ |
TNFα inhibitors | ↓↓ |
Tofacitinib (10 mg twice a day) | ↑ |
- Citation: Cheng K, Faye AS. Venous thromboembolism in inflammatory bowel disease. World J Gastroenterol 2020; 26(12): 1231-1241
- URL: https://www.wjgnet.com/1007-9327/full/v26/i12/1231.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i12.1231